NCT05304585 2026-02-24Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaChildren's Oncology GroupPhase 3 Recruiting205 enrolled
NCT06647953 2026-02-24Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaChildren's Oncology GroupPhase 3 Recruiting110 enrolled